All News

    First Patient with CD5-Positive T-Cell Lymphoma Dosed with MB-105

    April 22nd 2025, 4:14pm

    Article

    The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

    Oncodetect Test Aims to Detect Recurrence Risk Across Solid Tumors

    April 22nd 2025, 3:21pm

    Article

    The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence risk and treatment decisions.

    Imfinzi Combination Shows Efficacy in Bladder Cancer Treatment

    April 22nd 2025, 1:00pm

    Article

    Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder cancer, based on the NIAGARA trial.

    Aspiring to Make a Difference for Immigrants

    April 21st 2025, 9:00pm

    Article

    “Don’t aspire to make a living. Let’s aspire to make a difference in the Mandarin/Cantonese-speaking community.”

    Raising Awareness for Adolescents and Young Adults with Cancer

    April 21st 2025, 8:00pm

    Video

    Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.

    Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers

    April 21st 2025, 7:00pm

    Article

    Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian.

    My 11-Year Metastatic Breast Cancer Story Defied the Standard Path

    April 21st 2025, 5:00pm

    Article

    Diagnosed in 2014, I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

    Enhertu Combo Improves PFS in HER2+ Metastatic Breast Cancer

    April 21st 2025, 4:00pm

    Article

    Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive metastatic breast cancer.

    Trodelvy Plus Keytruda May Slow Progression in mTNBC

    April 21st 2025, 3:00pm

    Article

    In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.

    Pausing BTKi for Vaccine Did Not Boost Immunity in CLL

    April 21st 2025, 1:00pm

    Article

    Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be recommended, a trial found.